Hepatitis B and C: Risk of Liver Cancer

Skip to the navigation

Topic Overview

People who are infected with hepatitis B virus (HBV) or hepatitis C (HCV) virus may develop a chronic infection that can lead to cirrhosis. The damage that results increases the risk of liver cancer (hepatocellular carcinoma).

The risk of liver cancer is greater for people who have chronic HBV or HCV infection than for the general population.1

If you have chronic HBV infection:

  • You may develop liver cancer even if you do not have cirrhosis. But most people who have HBV and liver cancer also have cirrhosis.
  • Receiving antiviral therapy to treat chronic HBV infection may lower your risk for developing liver cancer.

If you have chronic HCV infection:

  • The strain (genotype) of HCV infection does not appear to affect your risk for developing liver cancer.
  • You are not at significant risk of developing cancer unless you also already have cirrhosis.
  • You are at greatly increased risk of liver cancer if you have alcohol-related cirrhosis in addition to hepatitis.
  • Receiving antiviral therapy to treat chronic HCV infection may lower your risk for developing liver cancer.2

Screening with ultrasound of the liver, liver function tests, and blood tests (including alpha-fetoprotein [AFP]) every 6 to 12 months is recommended for people at risk of liver cancer.

Health Tools Health Tools help you make wise health decisions or take action to improve your health.

Health Tools help you make wise health decisions or take action to improve your health.

Decision Points focus on key medical care decisions that are important to many health problems.Decision Points focus on key medical care decisions that are important to many health problems.

References

Citations

  1. Malet PF (2008). Chronic hepatitis. In DC Dale, DD Federman, eds., ACP Medicine, section 4, chap. 8. Hamilton, ON: BC Decker.
  2. Dienstag JL (2010). Chronic viral hepatitis. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th ed., vol. 1, pp. 1593–1670. Philadelphia: Churchill Livingstone Elsevier.

Credits

ByHealthwise Staff
Primary Medical ReviewerKathleen Romito, MD - Family Medicine
Specialist Medical ReviewerW. Thomas London, MD - Hepatology

Current as ofNovember 14, 2014

Current as of: November 14, 2014